Not finding it? Sign in to also search OpenAlex live.
-
LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Susana N. Banerjee, P.B. Ottevanger, Apostolos Sarivalasis, Romuald Le Scodan, Ana Montes, Judith R. Kroep, +9 more
4citations -
[ 89 Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2 -related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial
Jules P. J. Douwes, Annemijn L. Tops, Petra Dibbets‐Schneider, Berit M. Verbist, Constanza Fuentealba Bassaletti, Kimberley S. Koetsier, +10 more
0citations -
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thomas Karn, Tobias Meißner, Karsten Ernst Weber, Christine Solbach, Carsten Denkert, Knut Engels, +19 more
16citations -
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)2021 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Annelot G.J. van Rossum, Ingrid A.M. Mandjes, Erik D. van Werkhoven, Harm van Tinteren, A. Elise van Leeuwen‐Stok, Petra M. Nederlof, +7 more
9citations -
P17.24.B BEVACIZUMAB VERSUS DEXAMETHASONE AS FIRST-LINE TREATMENT FOR SYMPTOMATIC CEREBRAL RADIATION NECROSIS AFTER RADIATION OF HIGH GRADE GLIOMA OR BRAIN METASTASES: A RANDOMIZED CLINICAL TRIAL
Edith M.T. Dieleman, Vera C. Keil, Marit van Barreveld, Marcel G.W. Dijkgraaf, L Topff, Sander N Wagemakers, +6 more
0citations -
Bevacizumab for refractory gastrointestinal angiodysplasia: a case report and literature review2025 European Journal of Gastroenterology & Hepatology article Medicine Gastrointestinal Bleeding Diagnosis and Treatment Open access
Alicia Furumaya, Lia C. M. J. Goltstein, Maarten E. Tushuizen, Michael Klemt‐Kropp
4citations -
Cetuximab/irinotecan/5-FU +/-oxaliplatin or FOLFOXIRI +/- bevacizumab in patients with colorectal cancer and nonresectable liver metastases (AIO CELIM2-study).2020 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Treatments and Studies Open access
Gunnar Folprecht, Marika Mende, Torsten Liersch, Wolf O. Bechstein, Claus‐Henning Köhne, Alexander Stein, +10 more
13citations -
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study
Linda Dirven, Abigirl Machingura, Martin J. van den Bent, Corneel Coens, Andrew Bottomley, Alba Ariela Brandes, +7 more
7citations -
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
Jaap C. Reijneveld, Abigirl Machingura, Corneel Coens, MARTIN J.B. TAPHOORN, Walter Taal, Paul M. Clément, +10 more
13citations -
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol
Karlijn Verkerk, Soemeya F. Haj Mohammad, Laurien Joanna Zeverijn, Birgit S. Geurts, Ilse A.C. Spiekman, Florentine A.J. Verbeek, +11 more
2citations -
PEMBROLIZUMAB VS PLACEBO PLUS PACLITAXEL ± BEVACIZUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: RESULTS FROM THE PHASE 3 ENGOT-OV65/KEYNOTE-B96 STUDY2025 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment
Nicoletta Colombo, Emese Zsíros, Alexandra Sebastianelli, Mariusz Bidziński, Carlos Gallardo, Emad Matanes, +14 more
3citations